News items related to: Indonesia
-
Indonesian Advocates Challenge Big Pharma’s Patent of HIV Prevention and Treatment Lenacapavir
Indonesia AIDS Coalition (IAC), a community-based organization advocating on HIV-related issues, filed a post-grant opposition against the secondary (selection) patent...
-
The Rejection of the Bedaquiline Patent Opposition in Indonesia Raises the Risk of Difficulty in Accessing Optimal TB Therapy
The Indonesia AIDS Coalition (IAC) and Indonesia for Global Justice (IGJ) have filed a patent opposition for the Tuberculosis (TB)...
-
Indonesia Issues Government Use Licenses for Remdesivir and Favipiravir
Make Medicines Affordable Campaign and ITPC welcome the Presidential Decrees issued in Indonesia for government use licenses on remdesivir and...
-
MMA and ITPC’s 3rd POA: building capacity to challenge low quality patents
The Academies aim to provide practical training and capacity building for civil society groups and activists in challenging pharmaceutical patents...
-
From ally to active partner: Indonesia 62nd country to co-sponsor the TRIPS waiver
There is rapidly growing support for the TRIPS waiver – a proposal first tabled by India and South Africa –...
-
Activists urge Indonesia’s govt to resolve HIV drugs shortage amid COVID-19 pandemic
We reported how stockouts, since January this year, have been leaving people living with HIV without their essential treatment in...
-
Civil society demands an end to ARV stockouts in Indonesia
Our partner, the Indonesian AIDS Coalition (IAC) is one of 73 organizations, calling on the country’s Ministry of Health to...
-
Indonesia: Community action results in cheaper HIV treatment
First published by The Jakarta Post. Indonesia has an increasing rate of new HIV infections, with approximately 46,000 people newly...
-
The Indonesian patent club – and its impact on Hep C treatment
Communities are refusing to accept patent abuse – challenging unmerited patents, and finding ways around them in the meantime. Community...
